| AGEN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the AGEN shares outstanding history going back to 10/3/2011:
Also see: AGEN Market Cap History AGEN YTD Return |
AGEN Shares Outstanding History — Agenus Share Count Over Time
As of 5/7/2026 Agenus has 41.64 million AGEN shares outstanding. Investors often track the AGEN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows AGEN share count trends over time, with 54 historical shares outstanding datapoints presented, dating back to 10/3/2011.
| AGEN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AGEN Historical Shares Outstanding: +29.37% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AGEN Stock Price Chart |
| About Agenus Inc |
| Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is I-O, and its diverse pipeline is supported by its in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. We show 54 historical shares outstanding datapoints in our coverage of AGEN's shares outstanding history. Understanding the changing numbers of AGEN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AGEN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AGEN by allowing them to research AGEN shares outstanding history as well as any other stock in our coverage universe. |
| AGEN Current Stock Quote |
Quotes delayed 20 minutes  Free AGEN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| AGEN Share Performance |
| Shares Outstanding Peers |
| Agenus (AGEN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
AGIO Shares Outstanding History AGL Shares Outstanding History AGLE Shares Outstanding History AGN Shares Outstanding History AGPU Shares Outstanding History AGRX Shares Outstanding History AGTC Shares Outstanding History AGTI Shares Outstanding History AHCO Shares Outstanding History AHPI Shares Outstanding History More Healthcare companies » |
AGEN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
